Cancer Epidemiology

The epidemiology of cancer is the study of the features affecting cancer, as a way to assume possible trends and causes. The study of cancer epidemiology uses epidemiological methods to discover the source of cancer and to recognize and progress improved treatments.

This extent of study must resist with problems of lead time bias and length time bias. Lead time bias is the notion that early diagnosis may artificially inflate the survival statistics of a cancer, without really improving the usual history of the disease. Length bias is the concept that slower growing, more indolent tumors are more likely to be analyzed by screening tests, but improvements in diagnosing more cases of indolent cancer may not interpret into better patient outcomes after the implementation of screening programs.



 


    Related Conference of Cancer Epidemiology

    June 10-11, 2024

    8th Global Meeting on Oncology and Radiology

    Barcelona, Spain
    July 11-12, 2024

    24th World Congress on Cancer and Diagnostics

    Vancouver, Canada
    July 18-19, 2024

    14th World Congress on Breast Cancer

    Paris, France
    September 16-17, 2024

    9th World Conference on Breast and Cervical Cancer

    London, UK
    September 19-20, 2024

    25th World Congress on Cancer Summit

    Paris, France
    November 24-25, 2024

    7th International Conference on Anti-Cancer Drugs

    Vancouver, Canada

    Cancer Epidemiology Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in